ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers

September 28, 2012

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

April 30, 2010

NCI Advised To Seek Greater Local Contribution to Construction Projects; Other changes Asked

January 28, 1977

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004